Cholesterol-dependent infection of Burkitt's lymphoma cell lines by Epstein–Barr virus

References

1. Anderson H. A., Hiltbold E. M., Roche P. A. 2000; Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation. Nat Immunol 1:156–162
   [Google Scholar]
2. Bavari S., Bosio C. M., Wiegand E. 7 other authors 2002; Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med 195:593–602
   [Google Scholar]
3. Bolard J. 1986; How do the polyene macrolide antibiotics affect the cellular membrane properties?. Biochim Biophys Acta 864:257–304
   [Google Scholar]
4. Bouillon M., El Fakhry Y., Girouard J., Khalil H., Thibodeau J., Mourad W. 2003; Lipid raft-dependent and -independent signaling through HLA-DR molecules. J Biol Chem 278:7099–7107
   [Google Scholar]
5. Brown D. A., Jacobson K. 2001; Microdomains, lipid rafts and caveolae (San Feliu de Guixols, Spain, 19–24 May 2001). Traffic 2:668–672
   [Google Scholar]
6. Cherukuri A., Cheng P. C., Pierce S. K. 2001; The role of the CD19/CD21 complex in B cell processing and presentation of complement-tagged antigens. J Immunol 167:163–172
   [Google Scholar]
7. D'Addario M., Ahmad A., Morgan A., Menezes J. 2000; Binding of the Epstein–Barr virus major envelope glycoprotein gp350 results in the upregulation of the TNF- α gene expression in monocytic cells via NF- κ B involving PKC, PI3-K and tyrosine kinases. J Mol Biol 298:765–778
   [Google Scholar]
8. Fuller A. O., Perez-Romero P. 2002; Mechanisms of DNA virus infection: entry and early events. Front Biosci 7:d390–406
   [Google Scholar]
9. Guyader M., Kiyokawa E., Abrami L., Turelli P., Trono D. 2002; Role for human immunodeficiency virus type 1 membrane cholesterol in viral internalization. J Virol 76:10356–10364
   [Google Scholar]
10. Haan K. M., Kwok W. W., Longnecker R., Speck P. 2000; Epstein–Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor. J Virol 74:2451–2454
    [Google Scholar]
11. Haan K. M., Lee S. K., Longnecker R. 2001; Different functional domains in the cytoplasmic tail of glycoprotein B are involved in Epstein–Barr virus-induced membrane fusion. Virology 290:106–114
    [Google Scholar]
12. Haddad R. S., Hutt-Fletcher L. M. 1989; Depletion of glycoprotein gp85 from virosomes made with Epstein–Barr virus proteins abolishes their ability to fuse with virus receptor-bearing cells. J Virol 63:4998–5005
    [Google Scholar]
13. Hernandez L. D., Hoffman L. R., Wolfsberg T. G., White J. M. 1996; Virus–cell and cell–cell fusion. Annu Rev Cell Dev Biol 12:627–661
    [Google Scholar]
14. Hiltbold E. M., Poloso N. J., Roche P. A. 2003; MHC class II–peptide complexes and APC lipid rafts accumulate at the immunological synapse. J Immunol 170:1329–1338
    [Google Scholar]
15. Huby R. D., Dearman R. J., Kimber I. 1999; Intracellular phosphotyrosine induction by major histocompatibility complex class II requires co-aggregation with membrane rafts. J Biol Chem 274:22591–22596
    [Google Scholar]
16. Kieff E., Rickinson A. B. 2001; Epstein–Barr virus and its replication. In Fields Virology , 4th edn. pp  2511–2573 Edited by Knipe D. M., Howley P. M. Philadelphia: Lippincott Williams & Wilkins;
    [Google Scholar]
17. Klein U., Gimpl G., Fahrenholz F. 1995; Alteration of the myometrial plasma membrane cholesterol content with beta-cyclodextrin modulates the binding affinity of the oxytocin receptor. Biochemistry 34:13784–13793
    [Google Scholar]
18. Kurzchalia T. V., Parton R. G. 1999; Membrane microdomains and caveolae. Curr Opin Cell Biol 11:424–431
    [Google Scholar]
19. Li Q., Turk S. M., Hutt-Fletcher L. M. 1995; The Epstein–Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells. J Virol 69:3987–3994
    [Google Scholar]
20. Liebowitz D. 1998; Pathogenesis of Epstein–Barr virus. In Human Tumor Viruses pp  175–199 Edited by McCance D. J. Washington, DC: ASM Press;
    [Google Scholar]
21. Longnecker R. 1998; Molecular biology of Epstein–Barr virus. In Human Tumor Viruses pp  133–172 Edited by McCance D. J. Washington, DC: ASM Press;
    [Google Scholar]
22. Mañes S., del Real G., Martínez-A C. 2003; Pathogens: raft hijackers. Nat Rev Immunol 3:557–568
    [Google Scholar]
23. Mastromarino P., Conti C., Goldoni P., Hauttecoeur B., Orsi N. 1987; Characterization of membrane components of the erythrocyte involved in vesicular stomatitis virus attachment and fusion at acidic pH. J Gen Virol 68:2359–2369
    [Google Scholar]
24. Nemerow G. R., Cooper N. R. 1984; Early events in the infection of human B lymphocytes by Epstein–Barr virus: the internalization process. Virology 132:186–198
    [Google Scholar]
25. Nemerow G. R., Luxembourg A., Cooper N. R. 1994; CD21/CR2: its role in EBV infection and immune function. Epstein–Barr Virus Rep 1:59–64
    [Google Scholar]
26. Ohtani Y., Irie T., Uekama K., Fukunaga K., Pitha J. 1989; Differential effects of alpha-, beta- and gamma-cyclodextrins on human erythrocytes. Eur J Biochem 186:17–22
    [Google Scholar]
27. Popik W., Alce T. M., Au W. C. 2002; Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4⁺ T cells. J Virol 76:4709–4722
    [Google Scholar]
28. Rickinson A., Kieff E. 2001; Epstein–Barr virus. In Fields Virology , 4th edn. pp  2575–2627 Edited by Knipe D. M., Howley P. M. Philadelphia: Lippincott Williams & Wilkins;
    [Google Scholar]
29. Rothberg K. G., Ying Y. S., Kamen B. A., Anderson R. G. 1990; Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate. J Cell Biol 111:2931–2938
    [Google Scholar]
30. Scheiffele P., Roth M. G., Simons K. 1997; Interaction of influenza virus haemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain. EMBO J 16:5501–5508
    [Google Scholar]
31. Simons K., Ikonen E. 1997; Functional rafts in cell membranes. Nature 387:569–572
    [Google Scholar]
32. Simons K., Toomre D. 2000; Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1:31–39
    [Google Scholar]
33. Speck P., Longnecker R. 1999; Epstein–Barr virus (EBV) infection visualized by EGFP expression demonstrates dependence on known mediators of EBV entry. Arch Virol 144:1123–1137
    [Google Scholar]
34. Speck P., Haan K. M., Longnecker R. 2000; Epstein–Barr virus entry into cells. Virology 277:1–5
    [Google Scholar]
35. Spriggs M. K., Armitage R. J., Comeau M. R. 7 other authors 1996; The extracellular domain of the Epstein–Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation. J Virol 70:5557–5563
    [Google Scholar]
36. Tanner J., Weis J., Fearon D., Whang Y., Kieff E. 1987; Epstein–Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis. Cell 50:203–213
    [Google Scholar]
37. van der Goot F. G., Harder T. 2001; Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack. Semin Immunol 13:89–97
    [Google Scholar]
38. Waarts B. L., Bittman R., Wilschut J. 2002; Sphingolipid and cholesterol dependence of alphavirus membrane fusion. Lack of correlation with lipid raft formation in target liposomes. J Biol Chem 277:38141–38147
    [Google Scholar]
39. Wang X., Hutt-Fletcher L. M. 1998; Epstein–Barr virus lacking glycoprotein gp42 can bind to B cells but is not able to infect. J Virol 72:158–163
    [Google Scholar]
40. Yee J. K., Miyanohara A., LaPorte P., Bouic K., Burns J. C., Friedmann T. 1994; A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc Natl Acad Sci U S A 91:9564–9568
    [Google Scholar]